When identifying a disorder to treat during the stages of drug development,which of the following would likely NOT be determined?
A) The size of the population to be treated.
B) The likely toxic doses of the test drugs.
C) The current state of scientific knowledge on the disease or treatments for the disease.
D) The effectiveness of other treatments already on the market.

Question

Quizplus · Accepted Answer

Determining the likely toxic doses of test drugs is part of the safety assessment in drug development, not part of identifying a disorder to treat. Identifying a disorder involves understanding the disease, its prevalence, existing treatments, and gaps in current treatment options.

When Identifying a Disorder to Treat During the Stages of Drug